Human BioSystems signs non-binding LOI with San West
Under the terms of the non-binding letter of intent (LOI), San West would acquire 85% of the outstanding common stock of Human BioSystems, pursuant to the contemplated merger

Under the terms of the non-binding letter of intent (LOI), San West would acquire 85% of the outstanding common stock of Human BioSystems, pursuant to the contemplated merger

The agreement grants Huya the opportunity to collaborate with The Beijing Institute of Materia Medica (BIMM) on preclinical safety and efficacy, and clinical trial protocols. The agreement also

According to IntraOp, this is the third Mobetron that will be installed in China. In 2008, IntraOp installed Mobetrons in the China Academy of Medical Science and the

Novartis Venture Fund, Fountain Healthcare Partners, Inventages Venture Capital and Seroba Kernel Life Sciences all participated in the funding. Proceeds will support the advancement of Opsona’s clinical trials

According to the company, these CB2-selective cannabinoids are synthetic compounds which belong to the class of nonclassical cannabinoids and thus display fewer of the undesired psychotropic and cardiovascular

Each patch of Nabolin Felbinac 70 contains 70mg of felbinac, which is the highest dose as felbinac among non-prescription anti-inflammatory analgesic patches, to control pain or suppress inflammation,

In his role, Mr Kusserow will be responsible for leading the company’s strategic planning function as well as its merger and acquisition and venture-capital activities. He will report

Recruitment to the final arm of the global Phase III program has now closed. All patients have entered a four-week screening and baseline period, with at least 240

Interest expense for the fourth quarter declined significantly to $26,000 against $267,000 a year ago, primarily due to the retirement of a subordinated debt facility with Escalate Capital